ALKERMES | ALKS - Stock


ALKERMES reported $191M in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
AbbVie USD 4.94B 22M Sep/2025
Acadia Pharmaceuticals USD 29.1M 2.97M Sep/2025
ALKERMES USD 191M 927K Sep/2025
Amgen USD 6.35B 237M Sep/2025
Biogen USD 2.21B 64.9M Sep/2025
BioMarin Pharmaceutical USD 1.38B 42M Sep/2025
Bristol-Myers Squibb USD 2.76B 21M Sep/2025
Eli Lilly USD 12.18B 1.17B Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
Ionis Pharmaceuticals USD 10.47M 1.99M Sep/2025
J&J USD 14.15B 734M Sep/2025
Merck USD 6.44B 157M Sep/2025
Neurocrine Biosciences USD 69.3M 12.4M Sep/2025
Otsuka Holdings JPY 350.53B 42.43B Jun/2025
Pfizer USD 11.47B 201M Sep/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Vertex Pharmaceuticals USD 1.63B 127.5M Sep/2025